التفاصيل البيبلوغرافية
العنوان:
Surufatinib for the treatment of advanced extrapancreatic neuroendocrine tumors
المؤلفون:
Kelly Koral , Zhongguang Chen , Xiuhua Lu , Shibin Yan
المصدر:
Expert review of anticancer therapy . 21(9)
سنة النشر:
2021
مصطلحات موضوعية:
0301 basic medicine , Vascular Endothelial Growth Factor A , Indoles , medicine.drug_class , medicine.medical_treatment , Neuroendocrine tumors , Tyrosine-kinase inhibitor , Targeted therapy , 03 medical and health sciences , 0302 clinical medicine , medicine , Humans , Pharmacology (medical) , Protein Kinase Inhibitors , Sulfonamides , business.industry , Immune regulation , medicine.disease , respiratory tract diseases , Neuroendocrine Tumors , 030104 developmental biology , Pyrimidines , Oncology , 030220 oncology & carcinogenesis , Cancer research , Sulfatinib , business
الوصف:
Introduction: Surufatinib (also known as HMPL-012, sulfatinib) is a novel oral tyrosine kinase inhibitor (TKI), which has the dual activity of anti-angiogenesis and immune regulation. In December 2...
تدمد:
1744-8328
URL الوصول:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b6746e6b37b9802dc58762da1ab1880 https://pubmed.ncbi.nlm.nih.gov/34142932
رقم الأكسشن:
edsair.doi.dedup.....7b6746e6b37b9802dc58762da1ab1880
قاعدة البيانات:
OpenAIRE
PDF full text from Publisher 